Dentsply Sirona (XRAY) Misses Q4 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts XRAY Hot Sheet
Price: $11.38 -0.44%
EPS Growth %: -36.0%
Financial Fact:
Interest expense: 8.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -36.0%
Financial Fact:
Interest expense: 8.4M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Dentsply Sirona (NASDAQ: XRAY) reported Q4 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $961 million versus the consensus estimate of $927.6 million.
GUIDANCE:
Dentsply Sirona sees FY2026 EPS of $1.40-$1.50, versus the consensus of $1.50. Dentsply Sirona sees FY2026 revenue of $3.5-3.6 billion, versus the consensus of $3.674 billion.
For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
